BIOLIFE SOLUTIONS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.53 USD | +3.97% |
|
+10.53% | +7.88% |
Chart calendar BioLife Solutions, Inc.
06eff78e07325a4a32458.lNAdPnM8oXLDR1jr0qGbe9wy3dApBkxwoRx2jxJE2lk.3JdYd0UR1V-bFDGto9fBDbUGn7saTAoRznAS4nMP43SstnJPPFTPG7YBCQ~f9cdc0470a41e8febe227b1844a75a44
Upcoming events on BioLife Solutions, Inc.
Past events on BioLife Solutions, Inc.
| 2024-03-20 02:15 pm | Key Banc Virtual Conference - Fireside Chat |
| 2024-03-06 09:15 am | TD Cowen Health Care Conference - Fireside Chat |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:03 pm | Q4 2023 Earnings Release |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-09 04:03 pm | Q3 2023 Earnings Release |
| 2023-09-18 | Northland Capital Markets Institutional Investor Conference |
| 2023-08-08 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-08 04:03 pm | Q2 2023 Earnings Release |
| 2023-07-20 | Annual General Meeting |
| 2023-05-22 | B. Riley Securities Institutional Investor Conference |
| 2023-05-10 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-10 04:03 pm | Q1 2023 Earnings Release |
| 2023-03-23 01:30 pm | Analyst Day |
| 2023-03-20 | KeyBanc Life Sciences & MedTech Forum |
| 2023-03-16 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-16 04:03 pm | Q4 2022 Earnings Release |
| 2023-03-13 | Oppenheimer Healthcare Conference |
| 2023-03-06 | Cowen Health Care Conference |
| 2023-01-08 | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27,4 28,1 -2.58% | 48,1 46,9 2.54% | 119 118 0.74% | 162 161 0.61% | 143 143 -0.1% | 106 |
|
EBITDA Million USD | Released Forecast Spread | 5,65 5,06 11.76% | 8,31 6,06 37.09% | -1,09 3,26 -133.39% | 3,59 4,13 -13.18% | -4,66 -11,2 58.51% | 2,88 |
|
EBIT Million USD | Released Forecast Spread | 1,81 0,88 105.85% | -2,74 -1,49 -84.33% | -34,9 -24,4 -42.7% | -146 -104 -40.03% | -70,8 -73,0 2.96% | -44,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,52 9,16 3.92% | -0,60 3,93 -115.2% | -28,7 -18,9 -51.64% | -145 -90,2 -60.61% | -66,3 -67,9 2.37% | -47,7 |
|
Net income Million USD | Released Forecast Spread | 11,1 9,13 21.19% | 2,67 3,93 -32.08% | -8,38 -1,06 -692.85% | -140 -85,1 -64.22% | -66,4 -68,1 2.49% | -47,7 |
|
EPS USD | Released Forecast Spread | 0,42 0,33 27.7% | 0,09 0,17 -47.06% | -0,22 -0,03 -780% | -3,29 -2,28 -44.62% | -1,52 -1,57 2.88% | -1,06 |
| Announcement Date | 11/03/20 | 22/03/21 | 28/02/22 | 16/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 37,3 36,4 2.4% | 36,2 38,2 -5.19% | 40,5 39,2 3.48% | 40,7 42,1 -3.13% | 44,3 43,3 2.26% | 37,7 42,9 -12.2% | 39,5 43,6 -9.46% | 33,3 33,1 0.74% | 32,7 32,9 -0.45% | 26,0 | 24,2 | 26,6 | 28,9 | 27,1 |
|
EBITDA Million USD | Released Forecast Spread | -5,47 -1,35 -304.58% | -0,81 -2,57 68.28% | 1,50 -0,12 1345.83% | 1,45 1,55 -6.5% | 1,73 2,04 -15.48% | -1,93 0,01 -32250% | -1,15 0,33 -451.01% | -3,11 -6,79 54.2% | 0,69 -4,80 114.41% | -4,23 | 0,40 | 2,87 | 3,80 | 4,89 |
|
EBIT Million USD | Released Forecast Spread | -18,2 -7,74 -134.83% | -7,63 -10,9 30.12% | -76,3 -9,64 -691.22% | -11,4 -7,76 -46.95% | -49,3 -8,23 -498.42% | -13,6 -9,43 -44.24% | -15,3 -9,27 -64.91% | -28,8 -16,6 -73.38% | -13,2 -15,3 14.15% | -16,0 | -11,1 | -9,05 | -8,41 | -3,17 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,0 -7,30 -146.55% | -7,67 -11,0 30.11% | -76,3 -9,04 -744.3% | -10,6 -7,44 -41.97% | -49,3 -7,30 -575.23% | -13,6 -9,32 -46.11% | -10,2 -9,01 -13.11% | -29,0 -16,4 -76.42% | -13,4 -15,0 10.74% | -16,2 | -12,1 | -10,1 | -9,32 | -1,84 |
|
Net income Million USD | Released Forecast Spread | -15,2 -7,30 -108.63% | -7,07 -11,0 35.57% | -72,6 -9,04 -702.92% | -9,96 -7,24 -37.54% | -49,2 -7,21 -581.84% | -13,7 -9,17 -49.51% | -10,2 -9,07 -12.44% | -29,1 -16,4 -77.29% | -13,4 -15,1 11.12% | -16,3 | -12,1 | -10,1 | -9,22 | -1,84 |
|
EPS USD | Released Forecast Spread | -0,37 -0,17 -114.05% | -0,17 -0,26 33.77% | -1,71 -0,21 -703.34% | -0,23 -0,17 -36.44% | -1,15 -0,17 -589.99% | -0,32 -0,21 -50% | -0,23 -0,21 -9.52% | -0,67 -0,38 -78.67% | -0,30 -0,34 12.2% | -0,36 | -0,27 | -0,23 | -0,20 | -0,04 |
| Announcement Date | 28/02/22 | 09/05/22 | 09/08/22 | 09/11/22 | 16/03/23 | 10/05/23 | 08/08/23 | 09/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for BioLife Solutions, Inc.
| 2024-04-26 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-26 06:00 am | AVANTOR, INC.: Q1 2024 Earnings Release |
| 2024-04-25 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | SINOCARE INC.: Q4 2023 Earnings Release |
| 2024-04-25 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-25 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLFS Stock
- Calendar BioLife Solutions, Inc.
